☆ 4.6 Article

Predicting survival for patients with mesothelioma: development of the PLACE prognostic model

BMC CANCER (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Health Care Sciences & Services

Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer

Bruna M. M. Rocha et al.

Summary: This study compares prognostic factors in two international cohorts of patients with advanced cancer and establishes a prognostic framework for treatment. The study finds that despite geographical and socio-demographic differences, similar prognostic factors are associated with long-term survival in both the European and Brazilian cohorts.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2023)

添加到收藏夹

Article Oncology

Diagnosis of malignant pleural disease: Ultrasound as a detective probe

Gaetana Messina et al.

Summary: This study aims to evaluate thoracic ultrasound as an imaging modality with high sensitivity for the detection of malignant pleural involvement and to guide pleural biopsies. Thoracic ultrasound can easily define the precise location and nature of pleural thickening, and it has the advantages of being more economical and avoiding radiation risks.

THORACIC CANCER (2023)

添加到收藏夹

Article Oncology

Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma

Yue Jiang et al.

Summary: This study provides a comprehensive analysis of the prognostic value of AS events and SFs in MPM and establishes a SF-AS regulatory network. The drug sensitivity analysis shows decreased drug sensitivity in the high-risk group of the SF model.

CANCER MEDICINE (2023)

添加到收藏夹

Review Oncology

The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification

Jennifer L. Sauter et al.

Summary: The 2021 WHO Classification of Tumors of the Pleura and Pericardium has made substantial changes compared to the 2015 classification. These changes include the merging of pleural and pericardial tumors, renaming of certain tumor types, elimination of certain terms, addition of new classification categories, incorporation of new prognostic features, introduction of grading system, and identification of useful immunohistochemical markers.

JOURNAL OF THORACIC ONCOLOGY (2022)

添加到收藏夹

Article Oncology

The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016-2030

Yirui Zhai et al.

Summary: The incidence rate of malignant mesothelioma in China is predicted to increase, while the age-standardized incidence rate will remain stable, according to a Bayesian age-period-cohort prediction model.

TRANSLATIONAL LUNG CANCER RESEARCH (2022)

添加到收藏夹

Article Respiratory System

Improving outcomes in malignant pleural mesothelioma in an integrated health care system

Stephanie Ossowski et al.

Summary: Consolidating mesothelioma surgery to a specialized surgical team and conducting regular bidisciplinary review can increase the incorporation of surgical treatments in the management of patients with MPM.

JOURNAL OF THORACIC DISEASE (2022)

添加到收藏夹

Article Oncology

Establishment of predictive nomogram and web-based survival risk calculator for malignant pleural mesothelioma: A SEER database analysis

Sihao Chen et al.

Summary: This study developed a multivariate clinical prognostic model and a web-based survival risk calculator to accurately predict the survival of patients with malignant pleural mesothelioma (MPM). The model can assist clinicians in practicing individualized medicine.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Surgery

Diagnostic ability and its influenced factors of ultrasound-guided percutaneous pleural needle biopsy diagnosis for malignant pleural mesothelioma

Yuxin Zhang et al.

Summary: This study aimed to investigate the diagnostic value and influencing factors of ultrasound-guided percutaneous pleural needle biopsy (US-PPNB) for malignant pleural mesothelioma (MPM). The results showed that US-PPNB had a high diagnostic accuracy for MPM, and pleural thickness and needle size significantly impacted the accuracy.

FRONTIERS IN SURGERY (2022)

添加到收藏夹

Article Medicine, General & Internal

Factors affecting the life expectancy in malignant pleural mesothelioma: Our 10 years of studies and experience

Filiz Cimen et al.

Summary: This study aimed to investigate the clinical, laboratory, and radiological features of malignant pleural mesothelioma (MPM) and the prognostic effect of SUVmax according to PET/CT. It found that age, gender, neutrophil increase, pleural thickening, PET SUV max values, stage, histological type, asbestos exposure, and treatment regimen were key determinants of survival in MPM.

MEDICINE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer

Fumiaki Shiratori et al.

Summary: The purpose of this study was to evaluate the prognostic impact of preoperative serum calcium levels on patients with esophageal cancer. The results showed that preoperative low serum calcium levels were associated with advanced tumors, and the prognosis of the low calcium group was worse than that of the high calcium group.

ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY (2022)

添加到收藏夹

Article Medicine, General & Internal

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Paul Baas et al.

Summary: Nivolumab plus ipilimumab demonstrated significant improvement in overall survival compared to standard chemotherapy for unresectable malignant pleural mesothelioma. This first-in-class treatment regimen has been approved for previously untreated patients in the USA and showed promising outcomes with manageable adverse events.

LANCET (2021)

添加到收藏夹

Article Oncology

Clinical prognostic factors in pleural mesothelioma: best supportive care and anti-tumor treatments in a real-life setting

Thomas Ringgaard Petersen et al.

Summary: The study found that survival rates were higher in patients with malignant pleural mesothelioma who received anti-tumor treatment, with good performance score and female gender being positive prognostic factors for patients receiving best supportive care.

ACTA ONCOLOGICA (2021)

添加到收藏夹

Article Oncology

Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion

Shu Zhang et al.

Summary: Both LENT and BRIMS scores, using routinely available clinical variables, can stratify selected MPM and MPE patients into risk groups with statistically different survival.

THORACIC CANCER (2021)

添加到收藏夹

Review Oncology

Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms

Francesca Cersosimo et al.

Summary: Interaction among tumor cells, immune cells, stromal cells, and the extracellular matrix in the tumor microenvironment is crucial for supporting pro-tumor mechanisms such as drug resistance and metastases. Understanding the crosstalk between tumor and non-tumor cells is important for designing more effective anti-cancer therapeutic strategies. Studies have shown that the cellular and soluble components of the tumor microenvironment play a key role in cancer initiation and progression.

CANCERS (2021)

添加到收藏夹

Article Critical Care Medicine

The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma

Rachelle Asciak et al.

Summary: This study investigated the association between pleural fluid exposure and survival in patients with malignant pleural mesothelioma. The findings suggest that successful pleurodesis may be associated with improved survival, but the relationship between MPM exposure duration to pleural fluid and survival remains unclear within the limitations of this retrospective study. Future prospective studies are needed to further evaluate this potentially important mechanism.

CHEST (2021)

添加到收藏夹

Article Oncology

Mesothelioma Risk Score: A New Prognostic Pretreatment, Clinical-Molecular Algorithm for Malignant Pleural Mesothelioma

Beow Y. Yeap et al.

Summary: Novel prognostic models using tumor volume and molecular factors as predictors show improved accuracy in predicting outcomes for malignant pleural mesothelioma patients, compared to traditional clinical staging.

JOURNAL OF THORACIC ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Immunotherapy in malignant pleural mesothelioma: a review of literature data

Jessica Menis et al.

Summary: Malignant pleural mesothelioma is a rare and aggressive cancer associated with asbestos exposure, with no treatment advances in the past 15 years. Immune therapeutics development may be a potential direction for the future treatment of this disease.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

添加到收藏夹

Review Oncology

Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment

Valerie Gounant et al.

Summary: The incidence of MPM continues to rise due to occupational asbestos exposure, with molecular carcinogenesis involving alterations of several key genes. Current treatment options mainly include surgery and chemotherapy, with the recent emergence of ICIs showing promising results in improving survival rates.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)

添加到收藏夹

Article Respiratory System

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

Arnaud Scherpereel et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients

M. Pavic et al.

EJNMMI RESEARCH (2020)

添加到收藏夹

Article Oncology

Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group

J. Remon et al.

LUNG CANCER (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Serum Calcium Levels Before Antitumour Therapy Predict Clinical Outcomes in Patients with Nasopharyngeal Carcinoma

Sheng-Yan Huang et al.

ONCOTARGETS AND THERAPY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

Yuna Blum et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Oncology

The Value of COX-2, NF-κB, and Blood Routine Indexes in the Prognosis of Malignant Peritoneal Mesothelioma

Wenjie Yin et al.

ONCOLOGY RESEARCH AND TREATMENT (2019)

添加到收藏夹

Article Oncology

High systemic immune-inflammation index represents an unfavorable prognosis of malignant pleural mesothelioma

Ming Ma et al.

CANCER MANAGEMENT AND RESEARCH (2019)

添加到收藏夹

Article Oncology

Preoperative Hyponatremia And Hypocalcemia Predict Poor Prognosis In Elderly Gastric Cancer Patients

Jingxuan Xu et al.

CANCER MANAGEMENT AND RESEARCH (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study

Sahar A. Saddoughi et al.

ANNALS OF THORACIC SURGERY (2018)

添加到收藏夹

Review Oncology

Progress in the Management of Malignant Pleural Mesothelioma in 2017

Amanda J. McCambridge et al.

JOURNAL OF THORACIC ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis

Christos Chouaid et al.

CANCER MEDICINE (2018)

添加到收藏夹

Article Oncology

Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma

Elly Marcq et al.

ONCOIMMUNOLOGY (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Targeting calcium signaling in cancer therapy

Chaochu Cui et al.

ACTA PHARMACEUTICA SINICA B (2017)

添加到收藏夹

Review Oncology

Novel insights into mesothelioma biology and implications for therapy

Timothy A. Yap et al.

NATURE REVIEWS CANCER (2017)

添加到收藏夹

Review Oncology

The calcium-cancer signalling nexus

Gregory R. Monteith et al.

NATURE REVIEWS CANCER (2017)

添加到收藏夹

Review Oncology

Immunotherapy for malignant pleural mesothelioma: current status and future directions

Jordan Dozier et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Specimen weight and volume: important predictors of survival in malignant pleural mesotheliomaaEuro

Diana Y. Kircheva et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2016)

添加到收藏夹

Article Oncology

A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis

Fraser J. H. Brims et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma

Andrea Bille et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Gerard Zalcman et al.

LANCET (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma

Yuen Yee Cheng et al.

MOLECULAR CANCER (2016)

添加到收藏夹

Article Oncology

Prevalence of hypercalcemia among cancer patients in the United States

Victor M. Gastanaga et al.

CANCER MEDICINE (2016)

添加到收藏夹

Article Health Care Sciences & Services

A re neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?

Seda Tural Onur et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2016)

添加到收藏夹

Article Public, Environmental & Occupational Health

Prognostic value of the lymphocyte-to-monocyte ratio and other inflammatory markers in malignant pleural mesothelioma

Abdullah Cetin Tanrikulu et al.

ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prognostic Score of Long-Term Survival After Surgery for Malignant Pleural Mesothelioma: A Multicenter Analysis

Giovanni Leuzzi et al.

ANNALS OF THORACIC SURGERY (2015)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma

Emanuela Taioli et al.

DISEASE MARKERS (2015)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Tremelimumab for the treatment of malignant mesothelioma

Alice Guazzelli et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2015)

添加到收藏夹

Article Oncology

Biomarkers and prognostic factors for malignant pleural mesothelioma

Paolo Vigneri et al.

FUTURE ONCOLOGY (2015)

添加到收藏夹

Review Oncology

A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma A Review of 12 Years' Experience

Isabelle Opitz et al.

JOURNAL OF THORACIC ONCOLOGY (2015)

添加到收藏夹

Editorial Material Critical Care Medicine

Individualised management of malignant pleural effusion

Amelia O. Clive et al.

LANCET RESPIRATORY MEDICINE (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Women With Malignant Pleural Mesothelioma Have a Threefold Better Survival Rate Than Men

Emanuela Taioli et al.

ANNALS OF THORACIC SURGERY (2014)

添加到收藏夹

Article Oncology

Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales

A. Linton et al.

BRITISH JOURNAL OF CANCER (2014)

添加到收藏夹

Editorial Material Medicine, General & Internal

Surgical resection of mesothelioma: an evidence-free practice

Y. C. Gary Lee

LANCET (2014)

添加到收藏夹

Article Respiratory System

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score

Amelia O. Clive et al.

THORAX (2014)

添加到收藏夹

Review Oncology

Tumor lysis syndrome in solid tumors: an up to date review of the literature

Aibek E. Mirrakhimov et al.

RARE TUMORS (2014)

添加到收藏夹

Article Oncology

Prognostic Factors in Patients with Advanced Cancer: A Comparison of Clinicopathological Factors and the Development of an Inflammation-Based Prognostic System

Barry J. Laird et al.

CLINICAL CANCER RESEARCH (2013)

添加到收藏夹

Article Peripheral Vascular Disease

VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients

Jon E. Peterson et al.

ANGIOGENESIS (2012)

添加到收藏夹

Article Surgery

Pretreatment Serum C-Reactive Protein Levels Predict Benefit From Multimodality Treatment Including Radical Surgery in Malignant Pleural Mesothelioma A Retrospective Multicenter Analysis

Bahil Ghanim et al.

ANNALS OF SURGERY (2012)

添加到收藏夹

Article Cell Biology

Epigallocatechin-3-gallate induces mesothelioma cell death via H2O2-dependent T-type Ca2+ channel opening

Elia Ranzato et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)

添加到收藏夹

Article Oncology

Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma

David James Pinato et al.

JOURNAL OF THORACIC ONCOLOGY (2012)

添加到收藏夹

Article Oncology

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

Tom Treasure et al.

LANCET ONCOLOGY (2011)

添加到收藏夹

Review Endocrinology & Metabolism

CHEMOTHERAPY-INDUCED HYPOCALCEMIA

Pia Marie E. Ajero et al.

ENDOCRINE PRACTICE (2010)

添加到收藏夹

Article Oncology

Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population

Raja M. Flores et al.

JOURNAL OF THORACIC ONCOLOGY (2010)

添加到收藏夹

Article Oncology

Estrogen Receptor-β Affects the Prognosis of Human Malignant Mesothelioma

Giulia Pinton et al.

CANCER RESEARCH (2009)

添加到收藏夹

Review Oncology

Malignant Pleural Mesothelioma

Anne S. Tsao et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

添加到收藏夹

Article Oncology

Screening for Malignant Pleural Mesothelioma and Lung Cancer in Individuals with a History of Asbestos Exposure

Heidi C. Roberts et al.

JOURNAL OF THORACIC ONCOLOGY (2009)

添加到收藏夹

Article Oncology

Malignant Pleural Mesothelioma After Household Exposure to Asbestos

Anush V. Patel et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

添加到收藏夹

Article Oncology

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

NJ Vogelzang et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis

MG Alexandrakis et al.

RESPIRATORY MEDICINE (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.